| Systematic Review of Recommendations on the Use of Disease‐Modifying Antirheumatic Drugs in Patients With Rheumatoid Arthritis and Cancer MA Lopez‐Olivo, I Colmegna, AR Karpes Matusevich, SR Qi, NV Zamora, ... Arthritis Care & Research 72 (3), 309-318, 2020 | 36 | 2020 |
| Treatment sequences after discontinuing a tumor necrosis factor inhibitor in patients with rheumatoid arthritis: a comparison of cycling versus swapping strategies AR Karpes Matusevich, Z Duan, H Zhao, LS Lal, W Chan, ... Arthritis Care & Research 73 (10), 1461-1469, 2021 | 14 | 2021 |
| Polypharmacy and Cognition Function Among Rural Adults RS Rasu, N Shrestha, AR Karpes Matusevich, R Zalmai, S Large, ... Journal of Alzheimer's Disease 82 (2), 607-619, 2021 | 12 | 2021 |
| Safety and Efficacy of Influenza Vaccination in Patients Receiving Immune Checkpoint Inhibitors. Systematic Review with Meta-Analysis MA Lopez-Olivo, V Valerio, AR Karpes Matusevich, M Brizio, M Kwok, ... Vaccines 10 (8), 1195, 2022 | 11 | 2022 |
| Shorter length of hospital stay for hip fracture in those with dementia and without a known diagnosis of osteoporosis in the USA RN Rasu RS, Zalmai R, Karpes Matusevich AR, Hunt SL, Phadnis MA BMC Geriatrics 20 (1), 523, 2020 | 11* | 2020 |
| TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, randomised controlled trial RE Ware, BR Davis, WH Schultz, RC Brown, B Aygun, S Sarnaik, I Odame, ... Lancet (London, England) 387 (10019), 661, 2016 | 8 | 2016 |
| Systematic review of economic evaluations of cycling versus swapping in patients with rheumatoid arthritis after failure to tumor necrosis factor inhibitors. Karpes AR, Suarez-Almazor ME, Cantor SB Arthritis Care Res, 2019 | 6* | 2019 |
| Evaluation of a Virtual Networking Event for Emerging Women Leaders in Global Health S Iyengar, J Ehrlich, E Chung, AM Marconi, ARK Matusevich, ... Annals of Global Health 88 (1), 2022 | 3 | 2022 |
| Cost-utility analysis of treatment options after initial tumor necrosis factor inhibitor therapy discontinuation in patients with rheumatoid arthritis AR Karpes Matusevich, LS Lal, W Chan, JM Swint, SB Cantor, ... Journal of Managed Care & Specialty Pharmacy 27 (1), 73-83, 2021 | 3 | 2021 |
| Long-term Medication Adherence and Preventive vs Reactive Care Utilization Among Older Adults With Diabetes. AR Karpes Matusevich, C Xavier, RS Rasu American Journal of Managed Care 28 (10), 2022 | 2 | 2022 |
| COST-UTILITY ANALYSIS OF TREATMENT OPTIONS AFTER INITIAL TUMOR NECROSIS FACTOR INHIBITOR THERAPY FAILURE IN PATIENTS WITH RHEUMATOID ARTHRITIS AR Karpes Matusevich, L Lal, C Wenyaw, JM Swint, SB Cantor, ... VALUE IN HEALTH 23, S219-S219, 2020 | 1 | 2020 |
| PMS28 COST-UTILITY ANALYSIS OF TREATMENT OPTIONS AFTER INITIAL TUMOR NECROSIS FACTOR INHIBITOR THERAPY FAILURE IN PATIENTS WITH RHEUMATOID ARTHRITIS ARK Matusevich, L Lal, C Wenyaw, JM Swint, SB Cantor, ... Value in Health 23, S219, 2020 | 1 | 2020 |
| Recommendations on the Management of Rheumatoid Arthritis in Patients with Cancer: A Systematic Review of Clinical Practice Guidelines and Consensus Statements MA Lopez-Olivo, I Colmegna, A Matusevich, SR Qi, N Zamora, R Sharma, ... ARTHRITIS & RHEUMATOLOGY 69, 2017 | 1 | 2017 |
| Therapy in Patients with Rheumatoid Arthritis (RA) with Inadequate Response to Tumor Necrosis Factor Alpha Inhibitors (TNFi): A Systematic Review and Meta-Analysis of … MA Lopez-Olivo, A Matusevich, M Suarez-Almazor ARTHRITIS & RHEUMATOLOGY 68, 2016 | 1 | 2016 |
| An economic evaluation of physical activity and implications for its promotion A Matusevich, M Leshno, A Shmueli, M Brezis Hebrew University of Jerusalem, 2010 | 1 | 2010 |
| An Economic Evaluation of Physical Activity and Implications for Its Promotion M Leshno Jerusalem, Israel: Hebrew University of Jerusalem, 2009 | 1 | 2009 |
| The Optimal Initiation Timing for Cyclosporine in Allogeneic Transplantation, Earlier Is Better with the Price of Higher Rate of Chronic Gvhd. L Dray, A Matusevich, I Resnick, M Aker, S Samuel, R Or, MY Shapira Blood, The Journal of the American Society of Hematology 114 (22), 1143-1143, 2009 | 1 | 2009 |
| Evaluation of a Virtual Networking Event for Emerging Women Leaders in Global Health S Iyengar, J Ehrlich, E Chung, AM Marconi, ARK Matusevich, ... Ubiquity Press 88 (1), 2022 | | 2022 |
| Systematic review of recommendations on the use of disease-modifying antirheumatic drugs in rheumatoid arthritis and cancer: comment on the article by Lopez-Olivo et al Reply MA Lopez-Olivo, G Pratt, ME Suarez-Almazor, I Colmegna, AR Karpes, ... ARTHRITIS CARE & RESEARCH 72 (12), 1828-1829, 2020 | | 2020 |
| PBI42 DISCONTINUATION PLAYS A ROLE WHEN EVALUATING THE COST EFFECTIVENESS OF THE SECOND BIOLOGICAL DRUG FOR PATIENTS WITH RHEUMATOID ARTHRITIS AK Matusevich, R Rasu, L Lal, C Wenyaw, JM Swint, SB Cantor, ... Value in Health 23, S21, 2020 | | 2020 |
Maria A. Lopez-OlivoThe University of Texas, MD Anderson Cancer Center在 mdanderson.org 的电子邮件经过验证
